GL Pharm Tech Corp.
Develops incrementally modified drugs using advanced drug delivery technologies.
204840 | KO
Overview
Corporate Details
- ISIN(s):
- KR7204840003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 달래내로 46 성남글로벌융합센터 210호, 성남시
- Website:
- http://www.glpt.co.kr/
- Sector:
- Manufacturing
Description
GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-12-04 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 90.0 KB | ||
| 2020-12-04 00:00 |
투자판단관련주요경영사항(중소기업기술혁신개발사업(시장대응형) 국책과제 선정)
|
Korean | 9.1 KB | ||
| 2020-12-02 00:00 |
[기재정정]최대주주변경
|
Korean | 32.6 KB | ||
| 2020-12-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 78.9 KB | ||
| 2020-11-30 00:00 |
증권발행결과(자율공시)(제6회차 CB)
|
Korean | 5.9 KB | ||
| 2020-11-30 00:00 |
최대주주변경
|
Korean | 29.2 KB | ||
| 2020-11-30 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자)
|
Korean | 5.9 KB | ||
| 2020-11-23 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 35.3 KB | ||
| 2020-11-23 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 36.3 KB | ||
| 2020-11-20 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득(제2회차)
|
Korean | 11.3 KB | ||
| 2020-11-13 00:00 |
분기보고서 (2020.09)
|
Korean | 1.3 MB | ||
| 2020-09-29 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자)
|
Korean | 5.9 KB | ||
| 2020-09-25 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득(제2회차,제4회차)
|
Korean | 19.8 KB | ||
| 2020-09-23 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 21.5 KB | ||
| 2020-09-21 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 19.4 KB |
Automate Your Workflow. Get a real-time feed of all GL Pharm Tech Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GL Pharm Tech Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GL Pharm Tech Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
